You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Carcinoma, Ovarian Epithelial

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Ovarian Cancer Trial in Hangzhou (NKG2D CAR-NK)

Recruiting
  • Ovarian Cancer
  • NKG2D CAR-NK
  • Hangzhou, Zhejiang, China
    Zhejiang Cancer Hospital
Mar 26, 2023

Safety of Niraparib in Korean Primary and Recurrent Epithelial

Completed
  • Epithelial Ovarian Cancer
  • Seoul, Korea, Republic of
    Department of Obstetrics and Gynecology, University of Ulsan Col
Oct 11, 2023

Appraising Medical Trial Experiences of Ovarian Cancer Patients

Not yet recruiting
  • Ovarian Cancer
    • (no location specified)
    Mar 24, 2023

    Epithelial Ovarian Cancer, Ovarian Carcinoma Trial in Nijmegen (XP-DC vaccinations)

    Not yet recruiting
    • Epithelial Ovarian Cancer
    • Ovarian Carcinoma
    • XP-DC vaccinations
    • Nijmegen, Gelderland, Netherlands
      Radboud University Medical Center
    Mar 6, 2023

    Ovarian Cancer Trial in Maywood (Decitabine, Carboplatin, Paclitaxel)

    Not yet recruiting
    • Ovarian Cancer
    • Maywood, Illinois
      Loyola University Medical Center
    Aug 1, 2023

    Total Management of Ovarian Cancer

    Not yet recruiting
    • Tumor of Female Reproductive System
    • Ovarian Cancer
    • No intervention
    • (no location specified)
    Aug 30, 2023

    Low Grade Serous Ovarian Carcinoma and Uterine Involvement :

    Completed
    • Serous Ovarian Carcinoma
    • Low Grade Serous Ovarian Carcinoma
    • Rate of myometrial involvement in the population of 28 low grade serous ovarian carcinoma.
    • Lyon, France
      Hospices civils de Lyon
    Feb 14, 2023

    Ovarian Cancer Trial in Goyang (Cisplatin)

    Not yet recruiting
    • Ovarian Cancer
    • Goyang, Gyeonggi, Korea, Republic of
      National Cancer Center
    Apr 24, 2023

    Ovarian Cancer Recurrent Trial (Fluzopril Combined With Apatinib)

    Not yet recruiting
    • Ovarian Cancer Recurrent
    • Fluzopril Combined With Apatinib
    • (no location specified)
    Oct 22, 2023

    ctDNA Methylation for Detecting Ovarian Cancer

    Recruiting
    • Epithelial Ovarian Cancer
    • +8 more
    • Methylation assay
    • Beijing, Beijing, China
      Lei Li
    Mar 24, 2023

    Participation Patterns Among Recurrent Ovarian Cancer Patients

    Not yet recruiting
    • Recurrent Ovarian Cancer
      • San Francisco, California
        Power Life Sciences
      Sep 30, 2023

      Ex Vivo Drug Response and Clinical Outcome in Ovarian Cancer

      Recruiting
      • Epithelial Ovarian Cancer
      • Biological sample collection
      • Linz, Upper Austria, Austria
      • +2 more
      Sep 28, 2023

      Ovarian Cancer Trial in Rome (Tumor and blood sample)

      Recruiting
      • Ovarian Cancer
      • Tumor and blood sample
      • Rome, Italy
        Fondazione Policlinico Universitario Agostino Gemelli IRCCS
      Jul 18, 2023

      Epithelial Ovarian Cancer, Anemia, Iron Deficiency Anemia Trial in Madison (Iron Sucrose)

      Terminated
      • Epithelial Ovarian Cancer
      • +2 more
      • Iron Sucrose
      • Madison, Wisconsin
        University of Wisconsin Carbone Cancer Center
      Jan 3, 2023

      Serous Ovarian Cancer, Advanced Ovarian Cancer Trial (SC0191, Gemcitabine, Paclitaxel)

      Not yet recruiting
      • Serous Ovarian Cancer
      • Advanced Ovarian Cancer
      • (no location specified)
      Sep 20, 2023

      Advanced Ovarian Cancer Trial in Guangzhou (Plasmodium immunotherapy)

      Not yet recruiting
      • Advanced Ovarian Cancer
      • Plasmodium immunotherapy
      • Guangzhou, Guangdong, China
        The Third Affiliated Hospital of Southern Medical University
      Jul 5, 2023

      Ovarian Cancer Trial in Houston (Hyperpolarized 13-C-pyruvate)

      Not yet recruiting
      • Ovarian Cancer
      • Hyperpolarized 13-C-pyruvate
      • Houston, Texas
        M D Anderson Cancer Center
      May 10, 2023

      ctDNA Predicts Recurrence of Advanced Ovarian Cancer After

      Recruiting
      • Ovarian Cancer Stage IV
      • Ovarian Cancer Stage III
        • Guangzhou, Guangdong, China
          Sun Yat-Sen Memorial Hospital
        Aug 30, 2023

        Ovarian Cancer, Ovarian Tumor, Ovarian Tumor Epithelial Trial (MIRRORS Protocol, Standard Open Cytoreductive Surgery)

        Not yet recruiting
        • Ovarian Cancer
        • +5 more
        • MIRRORS Protocol
        • Standard Open Cytoreductive Surgery
        • (no location specified)
        Jul 17, 2023

        Ovarian Cancer, Fallopian Tube Carcinoma, Peritoneal Carcinoma Trial in Italy (carboplatin and paclitaxel followed by surgery)

        Active, not recruiting
        • Ovarian Cancer
        • +2 more
        • carboplatin and paclitaxel followed by surgery
        • Bologna, Italy
        • +4 more
        Dec 28, 2022

        Epithelial Ovarian Cancer Trial in Hangzhou (Pamiparib)

        Not yet recruiting
        • Epithelial Ovarian Cancer
        • Hangzhou, Zhejiang, China
          Zhejiang Cancer Hospital
        Aug 4, 2022

        Ovarian Cancer Trial in Pittsburgh (Olaparib tablet)

        Not yet recruiting
        • Ovarian Cancer
        • Olaparib tablet
        • Pittsburgh, Pennsylvania
          UPMC Hillman Cancer Center
        Nov 1, 2023

        Ovarian Cancer Trial in Seoul (Cellgram-DC)

        Terminated
        • Ovarian Cancer
        • Cellgram-DC
        • Seoul, Korea, Republic of
          Asan medical center
        Dec 29, 2022

        Ovarian Cancer Stage III, Ovarian Cancer Stage IV Trial (Artificial Intelligence)

        Not yet recruiting
        • Ovarian Cancer Stage III
        • Ovarian Cancer Stage IV
        • Artificial Intelligence
        • (no location specified)
        Aug 24, 2023

        Ovarian Cancer Trial in Birmingham (Carboplatin, olaparibp, embro)

        Not yet recruiting
        • Ovarian Cancer
        • Birmingham, Alabama
          O'Neal Comprehensive Cancer Center at UAB
        Jul 18, 2023